Interní Med. 2008; 10(11): 517-519

Effect of phytoestrogens on menopausal symptoms and breast cancer

prof. Ing. Jitka Moravcová CSc
Ústav chemie přírodních látek, VŠCHT Praha

High intake of phytoestrogens in foods has been proposed to be responsible for the lower endocrine cancer risk in Asia in comparison to West countries. However, results of both epidemiologic and clinical studies are often controversial and nowadays there are no data to support the idea that isoflavone consumption improves the prognosis of breast cancer patients. The article summarizes current knowledge on the biologic effects and exposure levels of phytoestrogens in particular from the point of breast cancer risk and improvement of menopausal symptomps. The attention is also focused on the generally accepted recommendations concerning the daily intake of phytoestrogens in food and food supplements.

Keywords: Key words: phytoestrogens, isoflavones, menopause, breast cancer, daily intake.

Published: January 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Moravcová J. Effect of phytoestrogens on menopausal symptoms and breast cancer. Interní Med. 2008;10(11):517-519.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Albertazzi P, Purdie D. The nature and utility of the phytoestrogens: a review of the evidence. Maturitas 2002; 42: 173-185. Go to original source... Go to PubMed...
    2. Bertoli S, Spadafranca A, Ravelli L, Foti P, Erba D, Testolin G, Battezzati A. Pilot study to assess isoflavone intake in middleaged Italian subjects. Int. J. Biomed. Sci. 2008; 4(1): 44-51.
    3. Hedelin M, Lof M, Olsson M, Adlercreutz H, Sandin S, Weiderpass E. Dietary phytoestrogens are not associated with risk of overall breast cancer but diets rich in coumestrol are inversely associated with risk of estrogen and progesterone receptor negative breast tumor in Swedish women. J. Nutr. 2008; 138 (5): 938-945. Go to original source... Go to PubMed...
    4. Horn-Ross PL, Hoggatt KJ, Lee MM. Phytoestrogens and thyroid cancer risk: The San Francisco bay area thyroid cancer study. Cancer Epidemiol. Biomark. Preven. 2002; 11 (1): 43-49.
    5. Johnson EB, Muto GM, Yanushpolsky EH, Mutter GL. Phytoestrogen supplementation and endometrial cancer. Obstet. Gynecol. 2001; 98 (5): 947-950. Go to original source...
    6. Jou HJ, Wu SC, Chang FW, Ling PY, Chu KS, Wu WH. Effect of intestinal production of eqoul on menopausal symptoms in women treated with soy isoflavones. Int. J. Gynecol. Obst. 2008; 102 (1): 44-49. Go to original source... Go to PubMed...
    7. Kaplan B, Aschkenazi-Steinberg S, Yogev Y, Nahum R, Suzlkes J, Phisher M. Gynecologists' trends and attitudes toward prescribing hormone replacement therapy during menopause. Menopause 2002; 9: 354-359. Go to original source... Go to PubMed...
    8. Loprinzi CL, Bartom BL, Sloan JA, Novotny PJ, Dakhil SR, Verdirame JD, Knutson WH, Kelaghan J, Christensen B. Mayo clinic and north central cancer treatment grouphot flash studies: a 20-year experience. Menopause 2008; 15 (4): 655-660. Go to original source... Go to PubMed...
    9. Mazur W, Adlercreutz H. Overview of naturally occuring endocrine-active substances in the human diet in relation to human health. Nutrition 2000; 16 (7-8): 654-658. Go to original source... Go to PubMed...
    10. Messina MJ, Wood CE. Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary. Nutr. J. 2008; 7: 17. doi: 10.1186/1475-2891-7-17. Go to original source... Go to PubMed...
    11. Moravcová J, Kleinová T. Fytoestrogeny ve výživě - přinášejí užitek nebo riziko? Chem Listy 2002; 96: 282-289.
    12. Parkin DM. Cancers of the breast, endometrium and ovary - geographic correlations. Eur. J. Cancer Clin. Oncol. 1989; 25: 1917-1925. Go to original source... Go to PubMed...
    13. Quella SK, Loprinzi CL, Barton DL, Knost JA, Sloan JA, LaVasseur BI, Swan D, Krupp KR, Miller KD, Novotny PJ. Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A north central cancer treatment group trial. J. Clin. Oncol. 2000; 18 (5): 1068-1074. Go to original source... Go to PubMed...
    14. Slanina J. Biologická a farmakologická aktivita lignanů. Chem. Listy 2000; 94 (2): 111-116.
    15. Slanina J, Táborská E. Příjem, biologická dostupnost a metabolizmus rostlinných polyfenolů u člověka. Chem Listy 2004; 98: 239-245.
    16. Tomar RS, Shiao R. Early life and adult exposure to isoflavones and breast cancer risk. J. Enviromet. Sci. Health Part C. 2008; 26 (2): 113-173. Go to original source... Go to PubMed...
    17. Touillaud MS, Thiebaut ACM, Fournier A, Niravong M, Boutron-Ruault MC, Clavel-Chapelon F. Dietary lignan intake and postmenopausal breats cancer risk by estrogen and progesterone receptor status. J. Nation. Cancer Inst. 2007; 99 (6): 475-486. Go to original source... Go to PubMed...
    18. Travis RC, Allen NE, Appleby PN, Spencer EA, Roddam AW, Key TJ. A prospective study of vegetarianism and isoflavone intake in relation to breast cancer risk in British women. Int. J. Cancer 2008; 122: 705-710. Go to original source... Go to PubMed...
    19. Whitten PL, Patisaul BH. Cross-species and interassay comparisons of phytoestrogen action. Enviroment. Health Perspect. 2001; 109 (1): 5-20. Go to original source... Go to PubMed...
    20. Wu AH, Yu MC, Tseng CC, Pike MC. Epidemiology of soy exposures and breast cancer risk. British J. Cancer 2008; 98 (1): 9-14. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.